Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYAN

Cyanotech (CYAN) Stock Price, News & Analysis

Cyanotech logo

About Cyanotech Stock (NASDAQ:CYAN)

Advanced Chart

Key Stats

Today's Range
$0.42
$0.42
50-Day Range
$2.83
$3.26
52-Week Range
$2.37
$6.29
Volume
N/A
Average Volume
3,483 shs
Market Capitalization
$3.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter.

CYAN Stock News Headlines

Missed the Run So Far? This Is Your Second Chance
According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up.
Q3 2025 Cyanotech Corp Earnings Call
See More Headlines

CYAN Stock Analysis - Frequently Asked Questions

Cyanotech Co. (NASDAQ:CYAN) announced its quarterly earnings results on Tuesday, November, 12th. The biotechnology company reported ($0.16) EPS for the quarter. The biotechnology company had revenue of $5.85 million for the quarter. Cyanotech had a negative trailing twelve-month return on equity of 44.71% and a negative net margin of 19.50%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyanotech investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), Allena Pharmaceuticals (ALNA), Clarivate (CCC), Karyopharm Therapeutics (KPTI) and Madrigal Pharmaceuticals (MDGL).

Company Calendar

Last Earnings
11/12/2024
Today
7/18/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:CYAN
CIK
768408
Employees
95
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.66)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.27 million
Net Margins
-19.50%
Pretax Margin
-19.48%
Return on Equity
-44.71%
Return on Assets
-19.12%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
1.06
Quick Ratio
0.28

Sales & Book Value

Annual Sales
$23.07 million
Price / Sales
0.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.33 per share
Price / Book
0.32

Miscellaneous

Outstanding Shares
7,160,000
Free Float
5,074,000
Market Cap
$3.00 million
Optionable
Not Optionable
Beta
-0.11
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:CYAN) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners